Mirum Pharmaceuticals, Inc.
Support and Resistance Levels
Past performance
News About MIRM
All events for MIRM
All deals for MIRM
Financial Ratios
Financial Statements
MIRM vs Sector & Peers
About Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018, Mirum Pharmaceuticals, Inc. operates from its headquarters in Foster City, California. Website mirumpharma.com
Headquarters Foster City, CA, US